Gender inequalities in the promptness of diagnosis of bladder and renal cancer after symptomatic presentation: evidence from secondary analysis of an English primary care audit survey
Georgios Lyratzopoulos, Gary A Abel, Sean McPhail, Richard D Neal, Gregory P Rubin, Georgios Lyratzopoulos, Gary A Abel, Sean McPhail, Richard D Neal, Gregory P Rubin
Abstract
Objectives: To explore whether women experience greater delays in the diagnosis of bladder and renal cancer when first presenting to a general practitioner with symptoms caused by those cancers and potential reasons for such gender inequalities.
Design: Prospective national audit survey of cancer diagnosis.
Setting: English primary care (2009-2010).
Participants: 920 patients with bladder and 398 patients with renal cancer (252 (27%) and 165 (42%), respectively, were women).
Primary and secondary outcome measures: Proportion of patients with three or more pre-referral consultations; number of days from first presentation to referral; proportion of patients who presented with haematuria and proportion of patients investigated in primary care.
Results: Women required three or more prereferral consultations more often than men (27% (95% CI 21% to 33%) vs 11% (9% to 14%) for bladder (p<0.001); and 30% (22% to 39%) vs 18% (13% to 25%) for renal cancer (p=0.025)) and had a greater number of days from presentation to referral. In multivariable analysis (adjusting for age, haematuria status and use of primary care-led investigations), being a woman was independently associated with higher odds of three or more pre-referral consultations (OR=3.29 (2.06 to 5.25, p<0.001) for bladder cancer; and OR=1.90 (1.06 to 3.42, p=0.031) for renal cancer). Although presentation with haematuria was associated with more timely diagnosis of bladder cancer, gender inequalities did not vary by haematuria status for either cancer (p=0.18 for bladder and p=0.27 for renal). Each year in the UK, approximately 700 women with either bladder or renal cancer experience a delayed diagnosis because of their gender, of whom more than a quarter (197, or 28%) present with haematuria.
Conclusions: There are notable gender inequalities in the timeliness of diagnosis of urological cancers. There is a need to both reinforce existing guidelines on haematuria investigation and develop new diagnostic decision aids and tests for patients who present without haematuria.
Keywords: PRIMARY CARE; PUBLIC HEALTH.
References
- Department of Health Improving outcomes: a strategy for cancer. 2011. (accessed Apr 2013).
- Prades J, Espinas JA, Font R, et al. Implementing a cancer fast-track programme between primary and secondary care in Catalonia (Spain): a mixed methods study. Br J Cancer 2011;105:753–9
- New South Wales Government Cancer Plan 2011–15. 2011. (accessed Apr 2013).
- Olesen F, Hansen RP, Vedsted P. Delay in diagnosis: the experience in Denmark. Br J Cancer 2009;101(Suppl 2):S5–8
- Cancer Care Ontario Diagnostic assessment programs: an environmental scan. 2009. https:// (accessed Apr 2013).
- Weller D, Vedsted P, Rubin G, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer 2012;106:1262–7
- Neal RD, Allgar VL. Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the ‘National Survey of NHS Patients: Cancer’. Br J Cancer 2005;92:1971–5
- Lyratzopoulos G, Neal RD, Barbiere JM, et al. Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol 2012;13:353–65
- Rarer Cancer Foundation Primary cause? An audit of the experience in primary care of rarer cancer patients. 2011. (accessed Apr 2013).
- Pancreatic Cancer UK Study for survival 2011. 2011. (accessed Apr 2013).
- The Roy Castle Lung Cancer Foundation Explaining variations in lung cancer in England. 2011. (accessed Apr 2013).
- Teenage Cancer Trust One in four teenage cancer patients forced to visit GP at least four times before referral. 2012. (accessed Apr 2013).
- Rachet B, Maringe C, Nur U, et al. Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol 2009;10:351–69
- Johnson EK, Daignault S, Zhang Y, et al. Patterns of hematuria referral to urologists: does a gender disparity exist? Urology 2008;72:498–502
- Rubin G, Elliott K, McPhail S, Royal College of General Practitioners National audit of cancer diagnosis in primary care. 2011. (accessed Apr 2013).
- Lyratzopoulos G, Abel GA, McPhail S, et al. Measures of promptness of cancer diagnosis in primary care: secondary analysis of national audit data on patients with 18 common and rarer cancers. Br J Cancer 2013;108:1550–1
- Department of Health National Cancer Patient Experience Survey 2011/12—National Report. report.pdf (accessed Apr 2013).
- Shephard EA, Stapley S, Neal RD, et al. Clinical features of bladder cancer in primary care. Br J Gen Pract 2012;62:e598–604
- Bruyninckx R, Buntinx F, Aertgeerts B, et al. The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice. Br J Gen Pract 2003;53:31–5
- Hippisley-Cox J, Coupland C. Identifying patients with suspected renal tract cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract 2012;62:e251–60
- Jones R, Latinovic R, Charlton J, et al. Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. BMJ 2007;334:1040.
- Shephard E, Neal R, Rose P, et al. Clinical features of kidney cancer in primary care: a case-control study using primary care records. Br J Gen Pract 2013;63:250–5
- National Institute for Health and Clinical Excellence Referral for suspected cancer: a clinical practice guideline. London: 2005. Clinical guideline 27. (accessed Apr 2013).
- He Y, Yucel R, Zaslavsky AM. Misreporting, missing data, and multiple imputation: improving accuracy of cancer registry databases. Chance (NY) 2008;21:55–8
- Nur U, Shack LG, Rachet B, et al. Modelling relative survival in the presence of incomplete data: a tutorial. Int J Epidemiol 2010; 39:118–28
- Lyratzopoulos G, Abel GA, Barbiere JM, et al. Variation in advanced stage at diagnosis of lung and female breast cancer in an English region 2006–2009. Br J Cancer 2012;106:1068–75
- Lyratzopoulos G, Abel GA, Brown CH, et al. Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer. Ann Oncol 2013;24:843–50
- Royston P. Multiple imputation of missing values: further update of ice, with an emphasis on interval censoring. Stata J 2007;7:445–64
- Office for National Statistics Cancer incidence and mortality in the United Kingdom, 2007–2009. (accessed Apr 2013).
- Wallace DM, Bryan RT, Dunn JA, et al. West Midlands Urological Research Group. Delay and survival in bladder cancer. BJU Int 2002;89:868–78
- Hollenbeck BK, Dunn RL, Ye Z, et al. Delays in diagnosis and bladder cancer mortality. Cancer 2010;116:5235–42
- Barbiere JM, Saeb-Parsy K, Greenberg DC, et al. Trends in the use of radiotherapy and radical surgery for patients with bladder urothelial cell carcinoma in East Anglia, 1995–2006. BJU Int 2011;108:1106–14
- Noon AP, Albertsen PC, Thomas F, et al. Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients. Br J Cancer 2013; 108:1534–40
- Nieder AM, Lotan Y, Nuss GR, et al. Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey. Urol Oncol 2010;28:500–3
- Hamilton W, Green T, Martins T, et al. Evaluation of risk assessment tools for suspected cancer in general practice. Br J Gen Pract 2013;63:30–6
Source: PubMed